Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway
Sunbin Ling(Zhejiang Provincial People's Hospital), Yan Li(International Peace Maternity & Child Health Hospital)
Cited by 97
Related Papers
Carbon Dots as a Potential Therapeutic Agent for the Treatment of Cancer‐Related Anemia
|Advanced Materials|2022|151
USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
|Molecular Oncology|2017|106
Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines
|Oncology Reports|2014|62
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I
|Cell Death and Disease|2017|60
Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma
|World Journal of Surgical Oncology|2019|52